Koyfin Home > Directory > Health Care > Amicus Therapeutics > Gross Profit

Amicus Therapeutics Gross Profit Chart (FOLD)

Amicus Therapeutics annual/quarterly Gross Profit from 2006 to 2018. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Amicus Therapeutics Gross Profit for the quarter ending December 12, 2018 was $28m a 50.24% increase of 14m year over year
  • Amicus Therapeutics Gross Profit for the last 12 months ending December 12, 2018 was $77m a 46.15% increase of 35m year over year
  • Amicus Therapeutics Annual Gross Profit for 2018 was $77m a 60.06% increase of 46m from 2017
  • Amicus Therapeutics Annual Gross Profit for 2017 was $31m a 86.56% increase of 27m from 2016
  • Amicus Therapeutics Annual Gross Profit for 2016 was $4m a 70.33% increase of 3m from 2015
Other Income Statement Metrics:
  • Amicus Therapeutics EBITDA for the quarter ending December 12, 2018 was $-68m a 20.09% decrease of -14m year over year
  • Amicus Therapeutics Net Income for the quarter ending December 12, 2018 was $-78m a 36.07% decrease of -28m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Gross Profit Data

12/2018$28m
09/2018$16m
06/2018$18m
03/2018$14m
12/2017$12m
09/2017$9m
06/2017$6m
03/2017$3m
12/2016$2m
09/2016$2m

Annual FOLD Gross Profit Data

2018$77m
2017$31m
2016$4m
2014$1m
2013$-13m
2012$-2m
2011$-3m
2010$-13m
2009$44m
2008$3m